Wolverine Trading
AMED

Wolverine Trading’s Amedisys AMED Stock Holding History

Wolverine Trading’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,300
Closed -$308K – 4452
2023
Q3 		$308K Buy
+3,300
New +$305K ﹤0.01% 3278
2022
Q2 		– Sell
-17,400
Closed -$3.01M – 4409
2022
Q1 		$3.01M Buy
+17,400
New +$2.6M ﹤0.01% 1416
2020
Q4 		– Sell
-9,700
Closed -$2.25M – 4749
2020
Q3 		$2.25M Buy
+9,700
New +$2.21M 0.01% 1383
2020
Q2 		– Sell
-3,100
Closed -$558K – 4517
2020
Q1 		$558K Sell
3,100
-400
-11% -$71.2K ﹤0.01% 2535
2019
Q4 		$585K Buy
+3,500
New +$521K ﹤0.01% 2924
2019
Q3 		– Sell
-11,100
Closed -$1.35M – 4243
2019
Q2 		$1.35M Buy
+11,100
New +$1.32M ﹤0.01% 1802
2019
Q1 		– Sell
-11,200
Closed -$1.29M – 4462
2018
Q4 		$1.29M Buy
11,200
+800
+8% +$94.3K ﹤0.01% 1763
2018
Q3 		$1.3M Buy
+10,400
New +$1.15M ﹤0.01% 2066
2016
Q4 		– Sell
-10,000
Closed -$473K – 4391
2016
Q3 		$473K Buy
+10,000
New +$499K ﹤0.01% 2638

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Wolverine Trading's AMED Position: Q2 2022 in Review

Wolverine Trading sold out of Amedisys (AMED) in Q2 2022, closing a stake of 3,282 shares — an estimated $567K sold.

Wolverine Trading first reported a position in AMED in Q3 2018 and held it in 5 quarters. The position peaked at $1.44M in Q3 2018. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Wolverine Trading reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 3,282 Amedisys shares in Q2 2022, an estimated $567K.
  • Wolverine Trading first reported a position in Amedisys in Q3 2018 and held it in 5 quarters.
  • Wolverine Trading's Amedisys position peaked at $1.44M in Q3 2018.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.